Qianjin Group

Qianjin Pharmaceutical, often referred to as Qianjin Group, is a leading Chinese pharmaceutical enterprise specializing in Traditional Chinese Medicine (TCM) and chemical drug manufacturing. The company is most famous for its proprietary brand, particularly the Fuke Qianjin Tablets, which have long held a dominant market share in the treatment of gynecological inflammatory diseases in China. Beyond its core TCM portfolio, the group has diversified into chemical generics, including treatments for cardiovascular and infectious diseases, as well as healthcare consumer goods like sanitary products and health supplements. Headquartered in Zhuzhou, Hunan Province, the company operates a comprehensive value chain encompassing R&D, large-scale GMP manufacturing, and an extensive retail pharmacy network. As a publicly traded entity on the Shanghai Stock Exchange, it maintains a strong reputation for quality and brand heritage within the Chinese healthcare market.